V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159093 | 20061029 | 1.61 | 95.6 | Adjuvant (A) | 2016-01-29 | 2016-02-18 | ECX | N | N | ECX | 100065155 |
| 20159094 | 20061030 | 1.66 | 83 | Neo-adjuvant (N) | 2018-12-21 | 2018-12-27 | ECX | N | N | ECX | 101121232 |
| 20159095 | 20061031 | 1.77 | 85.3 | Adjuvant (A) | 2019-07-12 | 2019-07-19 | CAPECITABINE + GEMCITABINE | 2 | null | CAPECITABINE + GEMCITABINE | 101287572 |
| 20159096 | 20061032 | 1.59 | 69.8 | Curative (C) | 2019-08-18 | 2019-08-18 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101205647 |
| 20159097 | 20061033 | 1.54 | 68.2 | Neo-adjuvant (N) | 2016-10-15 | 2016-10-30 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101494635 |
| 20159098 | 20061034 | 1.71 | 54.65 | Curative (C) | 2016-09-15 | 2016-10-05 | ECX | N | N | ECX | 100433848 |
| 20159099 | 20061035 | 1.74 | 76.4 | Adjuvant (A) | 2017-01-25 | 2017-01-25 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101298482 |
| 20159100 | 20061036 | 1.66 | 88 | Neo-adjuvant (N) | 2019-12-28 | 2020-01-22 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100748496 |
| 20159104 | 20061037 | 1.74 | 79.2 | Neo-adjuvant (N) | 2018-04-08 | 2018-04-09 | ECX | 02 | N | ECX | 101431389 |
| 20159105 | 20061038 | 1.5 | 74.4 | Palliative (P) | 2018-07-22 | 2018-07-31 | ECX | null | N | ECX | 100074972 |
| 20159106 | 20061039 | 1.72 | 79.6 | Palliative (P) | 2019-06-24 | 2019-07-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100119590 |
| 20159107 | 20061040 | null | 72.4 | Palliative (P) | 2019-03-25 | 2019-04-06 | ECX | N | null | ECX | 100111334 |
| 20159112 | 20061041 | 1.64 | 118.2 | Neo-adjuvant (N) | 2017-06-04 | 2017-06-11 | ECX | 02 | N | ECX | 101151826 |
| 20159113 | 20061042 | 1.59 | 62 | Palliative (P) | 2017-12-21 | 2017-12-21 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101631346 |
| 20159114 | 20061043 | 1.73 | 64 | Curative (C) | 2018-02-04 | 2018-02-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100078067 |
| 20159119 | 20061044 | 1.7 | 74 | Neo-adjuvant (N) | 2018-08-20 | 2018-08-29 | ECX | null | N | ECX | 100529117 |
| 20159120 | 20061045 | 1.73 | 99 | Neo-adjuvant (N) | 2019-10-04 | 2019-10-04 | ECX | 02 | null | ECX | 101102525 |
| 20159123 | 20061046 | 1.59 | 82.05 | Palliative (P) | 2019-04-26 | 2019-05-18 | ECX | N | null | ECX | 101622808 |
| 20159129 | 20061047 | 1.66 | 103.2 | null | 2018-12-19 | 2019-01-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100080847 |
| 20159130 | 20061048 | 1.65 | 63.2 | Palliative (P) | 2019-09-16 | 2019-10-01 | Gemcitabine + Capecitabine | null | N | ECX | 100684518 |
| 20159131 | 20061049 | 1.76 | 58.9 | Adjuvant (A) | 2019-10-15 | 2019-11-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101414469 |
| 20159133 | 20061050 | 1.57 | 83 | Adjuvant (A) | 2019-02-02 | 2019-02-16 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101802479 |
| 20159134 | 20061051 | 1.8 | 48.4 | Neo-adjuvant (N) | 2018-12-30 | 2019-01-09 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101567158 |
| 20159136 | 20061052 | 1.8 | 107 | Adjuvant (A) | 2020-02-07 | 2020-02-18 | CAPECITABINE + GEMCITABINE | 99 | N | CAPECITABINE + GEMCITABINE | 100496512 |
| 20159137 | 20061053 | 1.68 | 49.9 | Adjuvant (A) | 2017-12-28 | 2017-12-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100149703 |
| 20159140 | 20061054 | 1.71 | 55.7 | Adjuvant (A) | 2017-04-20 | 2017-05-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101224838 |
| 20159141 | 20061055 | 1.78 | 97.4 | Adjuvant (A) | 2017-03-17 | 2017-03-23 | ECX | 02 | N | ECX | 100001471 |
| 20159144 | 20061056 | 1.67 | 85.1 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-14 | ECX | 02 | N | ECX | 101057104 |
| 20159145 | 20061057 | 1.72 | 59 | Palliative (P) | 2016-08-11 | 2016-09-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101241145 |
| 20159148 | 20061058 | 1.8 | 76.25 | Neo-adjuvant (N) | 2016-02-12 | 2016-02-12 | ECX | 2 | N | ECX | 101870675 |
| 20159149 | 20061059 | 1.77 | 86.2 | null | 2017-11-28 | 2017-12-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100860087 |
| 20159152 | 20061060 | 1.58 | 74.8 | Neo-adjuvant (N) | 2017-11-23 | 2017-12-05 | ECX | N | N | ECX | 100377737 |
| 20159155 | 20061061 | 1.72 | 98.2 | Neo-adjuvant (N) | 2020-01-19 | 2020-01-31 | ECX | N | N | ECX | 101863097 |
| 20159156 | 20061062 | 1.53 | 77.9 | Adjuvant (A) | 2016-11-04 | 2016-11-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101549786 |
| 20159158 | 20061063 | 1.66 | 100.4 | Adjuvant (A) | 2016-11-09 | 2016-11-09 | ECX | 02 | N | ECX | 101786652 |
| 20159159 | 20061064 | 1.56 | 76.4 | Neo-adjuvant (N) | 2016-08-25 | 2016-09-30 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100575815 |
| 20159162 | 20061065 | 1.58 | 68.3 | Neo-adjuvant (N) | 2017-03-27 | 2017-04-04 | ECX | 2 | N | ECX | 100156277 |
| 20159163 | 20061066 | 1.63 | 67.8 | Palliative (P) | 2018-03-15 | 2018-03-22 | ECX | N | Y | CAPECITABINE + GEMCITABINE | 100277999 |
| 20159164 | 20061067 | 1.7 | 86.6 | Palliative (P) | 2018-03-12 | 2018-03-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100509780 |
| 20159165 | 20061068 | 1.62 | 62 | Adjuvant (A) | 2016-11-01 | 2016-11-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101378086 |
| 20159170 | 20061069 | 1.54 | 82.9 | Adjuvant (A) | 2020-03-18 | 2020-04-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100646292 |
| 20159171 | 20061070 | 1.72 | 86.8 | Neo-adjuvant (N) | 2019-06-08 | 2019-06-12 | ECX | 2 | N | ECX | 101592069 |
| 20159173 | 20061071 | 1.52 | 86.8 | Neo-adjuvant (N) | 2017-08-04 | 2017-08-14 | ECX | N | N | ECX | 100335301 |
| 20159174 | 20061072 | 1.69 | 46.8 | Palliative (P) | 2020-01-03 | 2020-01-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101198775 |
| 20159175 | 20061073 | 1.49 | 66.75 | Neo-adjuvant (N) | 2016-08-13 | 2016-08-21 | ECX | N | N | ECX | 100135719 |
| 20159179 | 20061074 | 1.68 | 83 | null | 2018-12-01 | 2018-12-01 | ECX | N | N | ECX | 101264330 |
| 20159180 | 20061075 | 1.8 | 96 | Adjuvant (A) | 2019-11-22 | 2019-12-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101762278 |
| 20159181 | 20061076 | 1.68 | 76.3 | Palliative (P) | 2017-12-24 | 2018-01-07 | ECX | 02 | N | ECX | 100175928 |
| 20159182 | 20061077 | 1.78 | 67.8 | null | 2018-10-16 | 2018-11-08 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100503708 |
| 20159183 | 20061078 | 1.68 | 61.8 | Palliative (P) | 2016-10-08 | 2016-10-21 | ECX | N | N | ECX | 100331889 |